These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 32488576

  • 21. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
    Noren NK, Lu M, Freeman AL, Koolpe M, Pasquale EB.
    Proc Natl Acad Sci U S A; 2004 Apr 13; 101(15):5583-8. PubMed ID: 15067119
    [Abstract] [Full Text] [Related]

  • 22. EphB4 overexpression in B16 melanoma cells affects arterial-venous patterning in tumor angiogenesis.
    Huang X, Yamada Y, Kidoya H, Naito H, Nagahama Y, Kong L, Katoh SY, Li WL, Ueno M, Takakura N.
    Cancer Res; 2007 Oct 15; 67(20):9800-8. PubMed ID: 17942910
    [Abstract] [Full Text] [Related]

  • 23. EphrinB2-EphB4 signals regulate formation and maintenance of funnel-shaped valves in corneal lymphatic capillaries.
    Katsuta H, Fukushima Y, Maruyama K, Hirashima M, Nishida K, Nishikawa S, Uemura A.
    Invest Ophthalmol Vis Sci; 2013 Jun 12; 54(6):4102-8. PubMed ID: 23696610
    [Abstract] [Full Text] [Related]

  • 24. EphrinB2 reverse signaling protects against capillary rarefaction and fibrosis after kidney injury.
    Kida Y, Ieronimakis N, Schrimpf C, Reyes M, Duffield JS.
    J Am Soc Nephrol; 2013 Mar 12; 24(4):559-72. PubMed ID: 23492730
    [Abstract] [Full Text] [Related]

  • 25. EphB4 promotes site-specific metastatic tumor cell dissemination by interacting with endothelial cell-expressed ephrinB2.
    Héroult M, Schaffner F, Pfaff D, Prahst C, Kirmse R, Kutschera S, Riedel M, Ludwig T, Vajkoczy P, Graeser R, Augustin HG.
    Mol Cancer Res; 2010 Oct 12; 8(10):1297-309. PubMed ID: 21047731
    [Abstract] [Full Text] [Related]

  • 26. Electric Acupuncture Treatment Promotes Angiogenesis in Rats with Middle Cerebral Artery Occlusion Through EphB4/EphrinB2 Mediated Src/PI3K Signal Pathway.
    Wu Y, Hu R, Zhong X, Zhang A, Pang B, Sun X, Zhu G.
    J Stroke Cerebrovasc Dis; 2021 Mar 12; 30(3):105165. PubMed ID: 33360522
    [Abstract] [Full Text] [Related]

  • 27. Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development.
    Cowan CA, Yokoyama N, Saxena A, Chumley MJ, Silvany RE, Baker LA, Srivastava D, Henkemeyer M.
    Dev Biol; 2004 Jul 15; 271(2):263-71. PubMed ID: 15223333
    [Abstract] [Full Text] [Related]

  • 28. EphrinB2 Activation Enhances Vascular Repair Mechanisms and Reduces Brain Swelling After Mild Cerebral Ischemia.
    Ghori A, Freimann FB, Nieminen-Kelhä M, Kremenetskaia I, Gertz K, Endres M, Vajkoczy P.
    Arterioscler Thromb Vasc Biol; 2017 May 15; 37(5):867-878. PubMed ID: 28254815
    [Abstract] [Full Text] [Related]

  • 29. [Effects of bidirectional EphB4-EphrinB2 signaling on bone remodeling].
    Fan WB, Zhao JN, Bao NR.
    Zhongguo Gu Shang; 2013 Aug 15; 26(8):705-8. PubMed ID: 24266083
    [Abstract] [Full Text] [Related]

  • 30. Activation of EphrinB2 Signaling Promotes Adaptive Venous Remodeling in Murine Arteriovenous Fistulae.
    Wang T, Liu J, Liu H, Lee SR, Gonzalez L, Gorecka J, Shu C, Dardik A.
    J Surg Res; 2021 Jun 15; 262():224-239. PubMed ID: 33039109
    [Abstract] [Full Text] [Related]

  • 31. The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth.
    Pennisi A, Ling W, Li X, Khan S, Shaughnessy JD, Barlogie B, Yaccoby S.
    Blood; 2009 Aug 27; 114(9):1803-12. PubMed ID: 19597185
    [Abstract] [Full Text] [Related]

  • 32. EphrinB2 and EphB4 expression in pterygia: new insights and preliminary results.
    Xue C, Huang Z, Wang J, Dong Y, Zhou X.
    Can J Ophthalmol; 2009 Apr 27; 44(2):185-8. PubMed ID: 19491953
    [Abstract] [Full Text] [Related]

  • 33. Dysregulation of the EphrinB2-EphB4 ratio in pediatric cerebral arteriovenous malformations is associated with endothelial cell dysfunction in vitro and functions as a novel noninvasive biomarker in patients.
    Fehnel KP, Penn DL, Duggins-Warf M, Gruber M, Pineda S, Sesen J, Moses-Gardner A, Shah N, Driscoll J, Zurakowski D, Orbach DB, Smith ER.
    Exp Mol Med; 2020 Apr 27; 52(4):658-671. PubMed ID: 32286515
    [Abstract] [Full Text] [Related]

  • 34. [Angiogenesis-targeted therapy: therapeutic potential for neurosurgical disorders].
    Abe T, Kamida T, Fujiki M, Kobayashi H.
    No Shinkei Geka; 2006 Feb 27; 34(2):123-32. PubMed ID: 16485558
    [No Abstract] [Full Text] [Related]

  • 35. Shear stress increases expression of the arterial endothelial marker ephrinB2 in murine ES cells via the VEGF-Notch signaling pathways.
    Masumura T, Yamamoto K, Shimizu N, Obi S, Ando J.
    Arterioscler Thromb Vasc Biol; 2009 Dec 27; 29(12):2125-31. PubMed ID: 19797707
    [Abstract] [Full Text] [Related]

  • 36. Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis.
    Djokovic D, Trindade A, Gigante J, Badenes M, Silva L, Liu R, Li X, Gong M, Krasnoperov V, Gill PS, Duarte A.
    BMC Cancer; 2010 Nov 23; 10():641. PubMed ID: 21092311
    [Abstract] [Full Text] [Related]

  • 37. Activation of multiple angiogenic signaling pathways in hemangiopericytoma.
    Pierscianek D, Michel A, Hindy NE, Keyvani K, Dammann P, Oezkan N, Mueller O, Sure U, Zhu Y.
    Brain Tumor Pathol; 2016 Jul 23; 33(3):200-8. PubMed ID: 26951238
    [Abstract] [Full Text] [Related]

  • 38. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
    Zamora DO, Davies MH, Planck SR, Rosenbaum JT, Powers MR.
    Invest Ophthalmol Vis Sci; 2005 Jun 23; 46(6):2175-82. PubMed ID: 15914639
    [Abstract] [Full Text] [Related]

  • 39. Transgenic expression of ephrinB2 in periodontal ligament stem cells (PDLSCs) modulates osteogenic differentiation via signaling crosstalk between ephrinB2 and EphB4 in PDLSCs and between PDLSCs and pre-osteoblasts within co-culture.
    Zhu SY, Wang PL, Liao CS, Yang YQ, Yuan CY, Wang S, Dissanayaka WL, Heng BC, Zhang CF.
    J Periodontal Res; 2017 Jun 23; 52(3):562-573. PubMed ID: 27763659
    [Abstract] [Full Text] [Related]

  • 40. EphrinB2-EphB4 Signaling in Neurooncological Disease.
    Piffko A, Uhl C, Vajkoczy P, Czabanka M, Broggini T.
    Int J Mol Sci; 2022 Jan 31; 23(3):. PubMed ID: 35163601
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.